Page 760 - Cardiac Nursing

8:3
1 A
M
e 7
9/0
9/2
009
36
ara
Apt
36
P
P
g
K34
0-c
30_
L L LWB
LWBK340-c30_30_p722-737.qxd 09/09/2009 08:31 AM Page 736 Aptara
K34
LWB K34 0-c 30_ p72 2-7 37. qxd 0 9/0 9/2 009 0 0 8:3 1 A M P a a g e 7 36 Apt ara
37.
qxd
0
p72
2-7
37.
736 PA R T I V / Pathophysiology and Management of Heart Disease
48. Fatkin, D. (2007). Guidelines for the diagnosis and management of fa- 71. Olivotto, I., Ommen, S. R., Maron, M. S., et al. (2007). Surgical myec-
milial dilated cardiomyopathy. Heart, Lung and Circulation, 16(1), 19–21. tomy versus alcohol septal ablation for obstructive hypertrophic car-
6
6
49. Kuhl, U., Pauschinger, M., Noutsias, M., et al. (2005). High prevalence diomyopathy. Will there ever be a randomized trial? Journal of the Amer-
of viral genomes and multiple viral infections in the myocardium of ican College of Cardiology, 50(9), 831–834.
adults with “idiopathic” left ventricular dysfunction. Circulation, 111(7), 72. Spirito, P., & Autore, C. (2006). Management of hypertrophic car-
887–893. diomyopathy. BMJ, 332(7552), 1251–1255.
50. Bowles, N. E., Ni, J., Kearney, D. L., et al. (2003). Detection of viruses 73. Seth, S., Thatai, D., Sharma, S., et al. (2004). Clinico-pathological eval-
in myocardial tissues by polymerase chain reaction. Evidence of aden- uation of restrictive cardiomyopathy (endomyocardial fibrosis and idio-
ovirus as a common cause of myocarditis in children and adults. Journal pathic restrictive cardiomyopathy) in India. European Journal of Heart
6
6
of the American College of Cardiology, 42(3), 466–472. Failure, 6(6), 723–729.
51. Friedewald, V. E., Jr., Boehmer, J. P., Kowal, R. C. (2007). The editor’s 74. Hassam, W., Fawzy, M., Helaly, S., et al. (2005). Pitfalls in diagnosis and
roundtable: Cardiac resynchronization therapy. American Journal Cardi- clinical, echocardiographic, and hemodynamic findings in endomyocar-
ology, 100(7), 1145–1152. dial fibrosis. Chest, 128(6), 3985–3992.
52. Hare, J. M. (2007). The dilated, restrictive, and infiltrative cardiomy- 75. Shah, K. B., Inoue, Y., & Mehra, M. R. (2006). Amyloidosis and the heart:
opathies. In P. Libby, R. O. Bonow, D. L. Mann, et al. (Eds.), Braun- A comprehensive review. Archives of Internal Medicine, 166(17), 1805–1813.
6
6
wald’s heart disease: A textbook of cardiovascular medicine (8th ed.). 76. Tandri, H., Saranathan, M., Rodriguez, E. R., et al. (2005). Noninvasive
Philadelphia: Saunders Elsevier. detection of myocardial fibrosis in arrhythmogenic right ventricular car-
53. Witteles, R. M., Tang, W. H., Jamali, A. H., et al. (2004). Insulin resist- diomyopathy using delayed-enhancement magnetic resonance imaging.
ance in idiopathic dilated cardiomyopathy: A possible etiologic link. Journal of the American College of Cardiology, 45(1), 98–103.
Journal of the American College of Cardiology, 44(1), 78–81. 77. Dalal, D., Nasir, K., Bomma, C., et al. (2005). Arrhythmogenic right ven-
54. Hunt, S., Abraham, W., & Chin, M. (2005). ACC/AHA 2005 guideline tricular dysplasia: A United States experience. Circulation, 112(25),
update for the diagnosis and management of chronic heart failure in the 3823–3832.
adult. Circulation, 112, e154–e235. 78. Hulot, J. S., Jouven, X., Empana, J. P., et al. (2004). Natural history and
55. Takemoto, Y., Hozumi, T., Sugioka, K., et al. (2007). Beta-blocker ther- risk stratification of arrhythmogenic right ventricular dysplasia/car-
apy induces ventricular resynchronization in dilated cardiomyopathy diomyopathy. Circulation, 110(14), 1879–1884.
with narrow QRS complex. Journal of the American College of Cardiology, 79. Buja, G., Estes, N. A., III, Wichter, T., et al. (2008). Arrhythmogenic
49(7), 778–783. right ventricular cardiomyopathy/dysplasia: Risk stratification and ther-
56. Neglia, D., De Maria, R., Masi, S., et al. (2007). Effects of long-term apy. Progress in Cardiovascular Diseases, 50(4), 282–293.
treatment with carvedilol on myocardial blood flow in idiopathic dilated 80. Baughman, K. (2006). Diagnosis of myocarditis: Death of Dallas crite-
cardiomyopathy. Heart, 93(7), 808–813. ria. Circulation, 113, 593–595.
57. Kadish, A., Dyer, A., Daubert, J. P., et al. (2004). Prophylactic defibril- 81. Magnani, J. W., & Dec, G. W. (2006). Myocarditis: Current trends in di-
lator implantation in patients with nonischemic dilated cardiomyopathy. agnosis and treatment. Circulation, 113(6), 876–890.
New England Journal of Medicine, 350(21), 2151–2158. 82. Eckart, R. E., Love, S. S., Atwood, J. E., et al. (2004). Incidence and fol-
58. Mann, D. L., Acker, M. A., Jessup, M., et al. (2007). Clinical evaluation low-up of inflammatory cardiac complications after smallpox vaccina-
of the CorCap Cardiac Support Device in patients with dilated car- tion. Journal of the American College of Cardiology, 44(1), 201–205.
diomyopathy. Annals of Thoracic Surgery, 84(4), 1226–1235. 83. Skouri, H. N., Dec, G. W., Friedrich, M. G., et al. (2006). Noninvasive
59. Bruce, J. (2005). Getting to the heart of cardiomyopathies. Nursing, imaging in myocarditis. Journal of the American College of Cardiology,
35(8), 44–47. 48(10), 2085–2093.
60. Robert Wood Johnson University Hospital. (2008). Advanced heart fail- 84. Hia, C. P., Yip, W. C., Tai, B. C., et al. (2004). Immunosuppressive ther-
ure and transplant cardiology program. Retrieved January 30, 2008, from apy in acute myocarditis: An 18 year systematic review. Archives of Dis-
http://www.rwjuh.edu/medical_services/heart_failure_transplant.html. ease in Childhood, 89(6), 580–584.
61. Swedberg, K., Cleland, J., Dargie, H., et al. (2005). Guidelines for the 85. Chen, H., Liu, J., & Yang, M. (2006). Corticosteroids for viral my-
diagnosis and treatment of chronic heart failure: Executive summary (up- ocarditis. Cochrane Database of Systematic Reviews, 4, CD004471. DOI:
4
4
date 2005): The Task Force for the Diagnosis and Treatment of Chronic 004410.001002/14651858.CD14004471.pub14651852.
Heart Failure of the European Society of Cardiology. European Heart 86. Robinson, J., Hartling, L., Vandermeer, B., et al. (2005). Intravenous
6
6
Journal, 26(11), 1115–1140. immunoglobulin for presumed viral myocarditis in children and
62. Maron, B. J., McKenna, W. J., Danielson, G. K., et al. (2003). American adults. Cochrane Database of Systematic Reviews, 1, CD004370. DOI:
College of Cardiology/European Society of Cardiology clinical expert 004310.001002/14651858.CD14004370.pub.14651852.
consensus document on hypertrophic cardiomyopathy. A report of the 87. Tang, W. H., & Francis, G. S. (2005). The year in heart failure. Journal
6
6
American College of Cardiology Foundation Task Force on Clinical Ex- of the American College of Cardiology, 46(11), 2125–2133.
pert Consensus Documents and the European Society of Cardiology 88. Statement Development Group, Garratt, C. J., Elliott, P. M., et al. (2008).
Committee for Practice Guidelines. Journal of the American College of Clinical indications for genetic testing in familial sudden cardiac death
Cardiology, 42(9), 1687–1713. syndromes: An HRUK Position Statement. Heart, 94(4), 502–507.
63. Maron, B. J., Thompson, P. D., Ackerman, M. J., et al. (2007). Recom- 89. Vollman, M. W. (1995). Dynamic cardiomyoplasty: Perspectives on
mendations and considerations related to preparticipation screening for nursing care and collaborative management. Progress in Cardiovascular
cardiovascular abnormalities in competitive athletes: 2007 update: A sci- Nursing, 10(2), 15–22.
entific statement from the American Heart Association Council on Nu- 90. Baddigam, K., Pierantonio, R., Russo, J., et al. (2005). Dexmedetomi-
trition, Physical Activity, and Metabolism: Endorsed by the American dine in the treatment of withdrawal symptoms in cardiothoracic surgery
College of Cardiology Foundation. Circulation, 115(12), 1643–1655. patients. Journal of Intensive Care Medicine, 20(2), 118–123.
64. Nishimura, R. A., & Holmes, D. R, Jr. (2004). Clinical practice. Hyper- 91. Koelling, T. M., Johnson, M. L., Cody, R. J., et al. (2005). Discharge ed-
trophic obstructive cardiomyopathy. New England Journal of Medicine, ucation improves clinical outcomes in patients with chronic heart failure.
350(13), 1320–1327. Circulation, 111(2), 179–185.
65. Elliott, P., & McKenna, W. J. (2004). Hypertrophic cardiomyopathy. 92. Bashore, T., Cabell, C. H., & Fowler, V. (2006). Update on infective en-
Lancet, 363(9424), 1881–1891. docarditis. Current Problems in Cardiology, 31, 274–352.
66. Jurynec, J. (2007). Hypertrophic cardiomyopathy: A review of etiology 93. Horstkotte, D., Follath, F., Gutschik, E., et al. (2004). Guidelines on
and treatment. Journal of Cardiovascular Nursing, 22(1), 65–73. prevention, diagnosis and treatment of infective endocarditis executive
67. Sherrid, M. V. (2006). Pathophysiology and treatment of hypertrophic summary: The Task Force on Infective Endocarditis of the European So-
cardiomyopathy. Progress in Cardiovascular Diseases, 49(2), 123–151. ciety of Cardiology. European Heart Journal, 25(3), 267–276.
68. Ho, C. Y., & Seidman, C. E. (2006). A contemporary approach to hy- 94. Miro, J., del Rio, A., & Mestres, C. (2002). Infective endocarditis in in-
pertrophic cardiomyopathy. Circulation, 113, e858–e862. travenous drug abusers and HIV-infected patients. Infectious Disease
69. Frenneaux, M. P. (2004). Assessing the risk of sudden cardiac death in a Clinics of North America, 16, 273–295.
6
6
patient with hypertrophic cardiomyopathy. Heart, 90(5), 570–575. 95. Karchmer, A., Bonow, R. O., Mann, D. L., et al. (2007). Infective en-
70. Knight, C. J. (2006). Alcohol septal ablation for obstructive hyper- docarditis. In P. Libby (Ed.), Braunwald’s heart disease: A textbook of car-
trophic cardiomyopathy. Heart, 92(9), 1339–1344. diovascular medicine (8th ed.). Philadelphia: Saunders Elsevier.